Get 20% lifetime commission for referring investors to digrin.com
here.
Matinas BioPharma Holdings, Inc. (MTNB) Financials
MTNB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 3.4 million | 1.6 million |
| March 31, 2026 | 5.9 million | 2.9 million |
| Dec. 31, 2025 | 7.2 million | 2.4 million |
| Sept. 30, 2025 | 9.7 million | 3.2 million |
MTNB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -1.8 million | 104000 |
| March 31, 2026 | -1.6 million | 113000 |
| Dec. 31, 2025 | -1.5 million | 217000 |
| Sept. 30, 2025 | -1.5 million | 253000 |
MTNB Net Income
No data available :(
MTNB Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 761000 | - | - |
| March 31, 2026 | 2.4 million | - | 1.2 million |
| Dec. 31, 2025 | 4.0 million | - | 1.4 million |
| Sept. 30, 2025 | 5.4 million | - | 2.3 million |
MTNB Shares Outstanding
MTNB Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | - | 1.6 million | - |
| March 31, 2026 | - | - | 1.9 million | - |
| Dec. 31, 2025 | - | - | 1.6 million | - |
| Sept. 30, 2025 | - | - | 1.5 million | - |
MTNB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | 4000 |
| March 31, 2026 | - | 74000 |
| Dec. 31, 2025 | - | -85000 |
| Sept. 30, 2025 | - | 114000 |
MTNB
Price: $2.37
52 week price:
Earnings Per Share: -1.15 USD
Exchange: ASE
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 237100
Market Capitalization: 1.2 million